{"id":"placebo-of-estrogen","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is an inert placebo preparation used in Phase 3 clinical trials to serve as a control comparator against active estrogen-based treatments. Placebos contain no pharmacologically active ingredients and are used to assess the true efficacy and safety of the investigational estrogen therapy by accounting for placebo effect and natural disease progression.","oneSentence":"A placebo formulation designed to mimic estrogen therapy for use as a control arm in clinical trials.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:15.603Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 clinical trials of estrogen-based therapies (specific indication unknown)"}]},"trialDetails":[{"nctId":"NCT07420218","phase":"PHASE4","title":"Menopausal Hormones and Sympathetic Activation","status":"NOT_YET_RECRUITING","sponsor":"University of Delaware","startDate":"2026-09-01","conditions":"Perimenopausal Women","enrollment":80},{"nctId":"NCT06533865","phase":"PHASE3","title":"Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-03-19","conditions":"FHA (Functional Hypothalamic Amenorrhea)","enrollment":114},{"nctId":"NCT06318403","phase":"PHASE2","title":"Estradiol Supplementation and Rotator Cuff Repair","status":"NOT_YET_RECRUITING","sponsor":"University of Utah","startDate":"2028-03","conditions":"Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome","enrollment":58},{"nctId":"NCT07085767","phase":"PHASE3","title":"Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer","status":"RECRUITING","sponsor":"Olema Pharmaceuticals, Inc.","startDate":"2025-11-03","conditions":"Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer","enrollment":1000},{"nctId":"NCT06382948","phase":"PHASE3","title":"Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.","status":"RECRUITING","sponsor":"MedSIR","startDate":"2024-12-05","conditions":"Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer","enrollment":240},{"nctId":"NCT04895358","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-06-18","conditions":"Breast Neoplasms","enrollment":340},{"nctId":"NCT00699751","phase":"PHASE3","title":"A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-06-12","conditions":"Hormone Refractory Prostate Cancer, Bone Metastases","enrollment":921},{"nctId":"NCT04546009","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-10-09","conditions":"Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer","enrollment":992},{"nctId":"NCT07419594","phase":"NA","title":"Estradiol and Intrusive Memories","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2024-08-19","conditions":"PTSD, Intrusive Memories, Intrusion Symptom","enrollment":273},{"nctId":"NCT06440967","phase":"PHASE3","title":"A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy","status":"RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2024-07-31","conditions":"Hot Flashes","enrollment":540},{"nctId":"NCT05317364","phase":"PHASE4","title":"Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2022-07-14","conditions":"Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence","enrollment":38},{"nctId":"NCT01674140","phase":"PHASE3","title":"S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2013-09-12","conditions":"Breast Cancer","enrollment":1939},{"nctId":"NCT04255160","phase":"PHASE4","title":"Impact of Estradiol on Endothelial Function in Peri-Menopausal Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Delaware","startDate":"2020-10-01","conditions":"Perimenopause, Vasodilation, Estrogen","enrollment":80},{"nctId":"NCT04650581","phase":"PHASE3","title":"Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2021-01-27","conditions":"Breast Cancer","enrollment":250},{"nctId":"NCT04964934","phase":"PHASE3","title":"Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-30","conditions":"ER-Positive HER2-Negative Breast Cancer","enrollment":315},{"nctId":"NCT04192266","phase":"PHASE3","title":"Estrogen and Fear in PTSD","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-06-24","conditions":"PTSD","enrollment":83},{"nctId":"NCT05365178","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2022-07-01","conditions":"HR-positive, HER2-negative Breast Neoplasms","enrollment":432},{"nctId":"NCT03837626","phase":"PHASE2, PHASE3","title":"ENAC Blockade and Arterial Stiffness","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2019-07-15","conditions":"Overweight and Obesity, Insulin Resistance","enrollment":137},{"nctId":"NCT06343870","phase":"PHASE3","title":"Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)","status":"RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2025-12-18","conditions":"Menopause, Testosterone Deficiency, Estrogen Deficiency","enrollment":140},{"nctId":"NCT05877235","phase":"NA","title":"Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:","status":"COMPLETED","sponsor":"InCor Heart Institute","startDate":"2021-10-03","conditions":"Coronary Artery Disease, Menopause","enrollment":60},{"nctId":"NCT05388656","phase":"PHASE4","title":"Estrogen Variability and Irritability During the Menopause Transition","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-06-15","conditions":"Menopause, Irritable Mood","enrollment":40},{"nctId":"NCT06369363","phase":"EARLY_PHASE1","title":"Estrogen Deficiency on Cardiovascular Risk","status":"NOT_YET_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-09","conditions":"Postmenopausal Symptoms, Cardiovascular Diseases","enrollment":20},{"nctId":"NCT01886794","phase":"PHASE4","title":"Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2013-06-06","conditions":"Pelvic Floor Disorders","enrollment":7},{"nctId":"NCT06191289","phase":"PHASE2","title":"Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality","status":"TERMINATED","sponsor":"University of Illinois at Chicago","startDate":"2024-03-16","conditions":"Suicide","enrollment":11},{"nctId":"NCT06610305","phase":"PHASE4","title":"Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-09-02","conditions":"Major Depressive Disorder","enrollment":75},{"nctId":"NCT02297438","phase":"PHASE3","title":"A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]","status":"COMPLETED","sponsor":"Pfizer","startDate":"2015-03-23","conditions":"Breast Neoplasms","enrollment":340},{"nctId":"NCT04711252","phase":"PHASE3","title":"A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-01-28","conditions":"ER-Positive HER2-Negative Breast Cancer","enrollment":1370},{"nctId":"NCT04265053","phase":"EARLY_PHASE1","title":"Human Cerebral Blood Flow Regulation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2021-04-12","conditions":"Cerebral Arterial Diseases","enrollment":110},{"nctId":"NCT05741060","phase":"PHASE2","title":"Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Akira Sekikawa","startDate":"2023-06-29","conditions":"Arterial Stiffness, White Matter Lesions, Cognitive Decline","enrollment":369},{"nctId":"NCT04111978","phase":"PHASE3","title":"MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)","status":"RECRUITING","sponsor":"Swiss GO Trial Group","startDate":"2020-11-05","conditions":"Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms","enrollment":540},{"nctId":"NCT03689543","phase":"PHASE2","title":"Estrogen Receptor Beta and Mood","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2019-05-23","conditions":"Perimenopause-Related Depression","enrollment":74},{"nctId":"NCT01370798","phase":"PHASE3","title":"Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2011-05-26","conditions":"Hypospadias","enrollment":244},{"nctId":"NCT02007512","phase":"PHASE2","title":"Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-12-16","conditions":"Breast Cancer","enrollment":247},{"nctId":"NCT06455969","phase":"PHASE4","title":"Adaptions and Resiliency to Multi-Stressor OpeRations","status":"RECRUITING","sponsor":"Bradley Nindl","startDate":"2024-07-15","conditions":"Musculoskeletal Injury, Hypogonadism","enrollment":120},{"nctId":"NCT03973229","phase":"EARLY_PHASE1","title":"Neuroendocrine Risk for PTSD in Women","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-11-11","conditions":"PTSD, Trauma","enrollment":250},{"nctId":"NCT03875378","phase":"PHASE2","title":"Transdermal Estrogen in Women With Anorexia Nervosa","status":"RECRUITING","sponsor":"Pouneh K. Fazeli, MD","startDate":"2020-08-28","conditions":"Anorexia Nervosa","enrollment":66},{"nctId":"NCT04833140","phase":"PHASE3","title":"Estrogen Administration for the Treatment of NASH in Postmenopausal Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-12-02","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":60},{"nctId":"NCT02730429","phase":"PHASE2","title":"Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer","status":"COMPLETED","sponsor":"Nordic Society of Gynaecological Oncology - Clinical Trials Unit","startDate":"2017-02-15","conditions":"Endometrial Cancer","enrollment":78},{"nctId":"NCT03725059","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-12-27","conditions":"Breast Cancer","enrollment":1240},{"nctId":"NCT04002934","phase":"PHASE2","title":"Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis","status":"COMPLETED","sponsor":"Riley Bove, MD","startDate":"2019-09-10","conditions":"Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting","enrollment":63},{"nctId":"NCT02274571","phase":"EARLY_PHASE1","title":"Raising Insulin Sensitivity in Post Menopause","status":"COMPLETED","sponsor":"Pennington Biomedical Research Center","startDate":"2015-09","conditions":"Menopause","enrollment":8},{"nctId":"NCT06969326","phase":"PHASE3","title":"Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-05-01","conditions":"Postoperative Bleeding, Gender Dysphoria, Hysterectomy","enrollment":48},{"nctId":"NCT03740204","phase":"PHASE2","title":"The Role of Estrogen in the Neurobiology of Eating Disorders","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2019-06-13","conditions":"Eating Disorders, Hypoestrogenemia","enrollment":120},{"nctId":"NCT06508944","phase":"PHASE4","title":"Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2024-04-08","conditions":"Lower Urinary Tract Symptoms, Female Genitourinary Disease, Urinary Stress Incontinence","enrollment":86},{"nctId":"NCT06798571","phase":"PHASE4","title":"Role of Menopause in Thermoregulation","status":"RECRUITING","sponsor":"Penn State University","startDate":"2025-03-01","conditions":"Menopause, Aging","enrollment":24},{"nctId":"NCT06905210","phase":"PHASE3","title":"Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-03","conditions":"Acne Vulgaris, Acne Vulgaris on the Face","enrollment":526},{"nctId":"NCT03663543","phase":"PHASE1, PHASE2","title":"Intravenous Estrogen in Kidney Transplant Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2016-08-26","conditions":"Ischemia Reperfusion Injury","enrollment":30},{"nctId":"NCT00687739","phase":"PHASE3","title":"Prevention of Obesity in Women Via Estradiol Regulation","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2008-05","conditions":"Obesity","enrollment":79},{"nctId":"NCT03018366","phase":"PHASE2","title":"Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-01-01","conditions":"Estrogen Deficiency, Cardiovascular Disease (CVD), Functional Hypothalamic Amenorrhea","enrollment":29},{"nctId":"NCT05282277","phase":"PHASE4","title":"Examining the Effects of Estradiol on Neural and Molecular Response to Reward","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-20","conditions":"Depression, Psychosis, Anhedonia","enrollment":103},{"nctId":"NCT03436992","phase":"NA","title":"Estrogen and Diabetes","status":"COMPLETED","sponsor":"Augusta University","startDate":"2018-04-17","conditions":"Diabetes Mellitus, Type 1","enrollment":143},{"nctId":"NCT02694809","phase":"PHASE2","title":"The PROMISE Study: Duavee in Women With DCIS","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2017-01","conditions":"Ductal Breast Carcinoma In Situ, Postmenopausal","enrollment":142},{"nctId":"NCT01573442","phase":"PHASE3","title":"Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2013-09-10","conditions":"Arthralgia, Breast Cancer, Hot Flashes","enrollment":227},{"nctId":"NCT04615273","phase":"PHASE3","title":"A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2020-12-03","conditions":"Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency","enrollment":264},{"nctId":"NCT04109066","phase":"PHASE3","title":"Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2019-11-18","conditions":"Breast Cancer","enrollment":521},{"nctId":"NCT01216176","phase":"PHASE1, PHASE2","title":"A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer","status":"COMPLETED","sponsor":"Joyce Marie Slingerland, MD","startDate":"2008-10-21","conditions":"Breast Cancer","enrollment":71},{"nctId":"NCT00696111","phase":"NA","title":"Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2007-12","conditions":"Polycystic Ovary Syndrome, Obstructive Sleep Apnea","enrollment":18},{"nctId":"NCT05283421","phase":"NA","title":"Improving Diagnostics in Cervical Dysplasia","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2023-08-23","conditions":"Cervical Cancer","enrollment":150},{"nctId":"NCT02632045","phase":"PHASE2","title":"Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer","status":"COMPLETED","sponsor":"Melissa K Accordino","startDate":"2016-03","conditions":"Metastatic Breast Cancer, Breast Carcinoma","enrollment":169},{"nctId":"NCT01740427","phase":"PHASE3","title":"A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-02-22","conditions":"Breast Neoplasms","enrollment":666},{"nctId":"NCT02383823","phase":"NA","title":"Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects","status":"WITHDRAWN","sponsor":"Herning Hospital","startDate":"2019-08-10","conditions":"Menopause","enrollment":""},{"nctId":"NCT02758431","phase":"NA","title":"Cardiovascular Outcomes of Low Testosterone","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2016-07-01","conditions":"Hypogonadism","enrollment":232},{"nctId":"NCT01648751","phase":"NA","title":"Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse","status":"TERMINATED","sponsor":"Pamela Moalli","startDate":"2012-05","conditions":"Pelvic Organ Prolapse","enrollment":21},{"nctId":"NCT05221021","phase":"PHASE4","title":"Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome","status":"RECRUITING","sponsor":"Walter Reed National Military Medical Center","startDate":"2022-10-01","conditions":"Overactive Bladder Syndrome","enrollment":152},{"nctId":"NCT00725374","phase":"PHASE3","title":"A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12-15","conditions":"Breast Cancer","enrollment":102},{"nctId":"NCT06531668","phase":"NA","title":"A Clinical Trial to Examine the Efficacy of a Supplement to Support Hormone Regulation in Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Scale Media Inc","startDate":"2024-06-07","conditions":"Hormone Regulation","enrollment":50},{"nctId":"NCT00290251","phase":"PHASE2","title":"Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2006-02","conditions":"Leiomyoma","enrollment":72},{"nctId":"NCT02599714","phase":"PHASE1","title":"Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-12-07","conditions":"Advanced and Metastatic Breast Cancer","enrollment":54},{"nctId":"NCT05586724","phase":"PHASE3","title":"Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy","status":"RECRUITING","sponsor":"Angelica Lindén Hirschberg","startDate":"2022-03-15","conditions":"Menopausal Symptoms","enrollment":520},{"nctId":"NCT05073237","phase":"PHASE2","title":"Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans","status":"WITHDRAWN","sponsor":"VA Office of Research and Development","startDate":"2024-04-08","conditions":"Menopause, Prediabetes, Obesity","enrollment":""},{"nctId":"NCT04588740","phase":"PHASE1","title":"Inorganic Nitrate: Sex Differences in Muscle Contractile Function and Efficiency","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2020-01-20","conditions":"Healthy","enrollment":35},{"nctId":"NCT02624388","phase":"PHASE2","title":"Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)","status":"TERMINATED","sponsor":"University of Virginia","startDate":"2016-08","conditions":"Lymphoma, Childhood Lymphoma, Solid Tumor","enrollment":4},{"nctId":"NCT04671966","phase":"PHASE4","title":"Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction","status":"UNKNOWN","sponsor":"The University of Texas at Arlington","startDate":"2018-09-13","conditions":"Heart Diseases, Left Ventricular Dysfunction","enrollment":100},{"nctId":"NCT04460807","phase":"PHASE3","title":"Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer","status":"TERMINATED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2020-02-13","conditions":"Ovarian Cancer","enrollment":23},{"nctId":"NCT03312738","phase":"PHASE2","title":"A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2017-09-15","conditions":"Advanced Breast Cancer","enrollment":159},{"nctId":"NCT04043520","phase":"PHASE4","title":"Bioenergetic Effects of Aging and Menopause (BEAM)","status":"UNKNOWN","sponsor":"University of Colorado, Denver","startDate":"2019-09-24","conditions":"Menopause, Obesity, Abdominal, Aging","enrollment":57},{"nctId":"NCT02422615","phase":"PHASE3","title":"Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2015-06-09","conditions":"Advanced Breast Cancer","enrollment":726},{"nctId":"NCT01481883","phase":"PHASE4","title":"Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?","status":"COMPLETED","sponsor":"The Alfred","startDate":"2012-01","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":13},{"nctId":"NCT01101438","phase":"PHASE3","title":"A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer","status":"COMPLETED","sponsor":"Canadian Cancer Trials Group","startDate":"2010-08-13","conditions":"Breast Cancer","enrollment":3649},{"nctId":"NCT02431897","phase":"PHASE4","title":"Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2016-12","conditions":"Pelvic Organ Prolapse, Urogenital Prolapse, Vaginal Vault Prolapse","enrollment":206},{"nctId":"NCT02598557","phase":"PHASE2","title":"Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2016-12-06","conditions":"Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7","enrollment":180},{"nctId":"NCT00556374","phase":"PHASE3","title":"Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy","status":"COMPLETED","sponsor":"Amgen","startDate":"2006-12-18","conditions":"Breast Cancer","enrollment":3420},{"nctId":"NCT03718494","phase":"","title":"Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2019-05-22","conditions":"Alzheimer Dementia","enrollment":299},{"nctId":"NCT04865029","phase":"PHASE2","title":"Estradiol and Progesterone in Hospitalized COVID-19 Patients","status":"TERMINATED","sponsor":"Tulane University","startDate":"2021-07-22","conditions":"Covid19","enrollment":10},{"nctId":"NCT02237079","phase":"PHASE4","title":"Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)","status":"COMPLETED","sponsor":"Tulane University Health Sciences Center","startDate":"2014-12","conditions":"Obesity, Glucose Homeostasis, Postmenopausal Symptoms","enrollment":17},{"nctId":"NCT03097120","phase":"PHASE3","title":"The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"1995-01","conditions":"Heart Disease","enrollment":309},{"nctId":"NCT04471805","phase":"NA","title":"4 mA tDCS, Estrogen, and Leg Muscle Fatigability","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2020-10-01","conditions":"Healthy","enrollment":10},{"nctId":"NCT02385916","phase":"NA","title":"The Effects of EstroSense®/MD vs Placebo in Improving the Estrogen Profile in Females","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2015-04","conditions":"Estrogen Profile","enrollment":120},{"nctId":"NCT05753098","phase":"PHASE4","title":"Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2021-01-15","conditions":"Subfertility, Female","enrollment":148},{"nctId":"NCT00203996","phase":"PHASE4","title":"Polycystic Ovary Syndrome (PCOS) and Sleep Apnea","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2003-09","conditions":"Polycystic Ovary Syndrome, Obstructive Sleep Apnea","enrollment":37},{"nctId":"NCT02213757","phase":"PHASE4","title":"Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)","status":"TERMINATED","sponsor":"Medstar Health Research Institute","startDate":"2014-08","conditions":"Microscopic Hematuria","enrollment":29},{"nctId":"NCT01625286","phase":"PHASE1, PHASE2","title":"Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-10-03","conditions":"Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast Cancer","enrollment":148},{"nctId":"NCT00114517","phase":"PHASE2","title":"ELITE: Early Versus Late Intervention Trial With Estradiol","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2004-07","conditions":"Atherosclerosis","enrollment":643},{"nctId":"NCT00694733","phase":"NA","title":"Regulation of Cortisol Metabolism and Fat Patterning","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2005-05","conditions":"Obesity, Menopausal Syndrome","enrollment":140},{"nctId":"NCT01598298","phase":"PHASE3","title":"S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2013-05-15","conditions":"Breast Cancer, Musculoskeletal Complications, Pain","enrollment":299},{"nctId":"NCT04258410","phase":"PHASE4","title":"Quercetin for Cardio-Skeletal Muscle Health and Estrogen Deficiency","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2022-09","conditions":"Menopause Related Conditions","enrollment":""},{"nctId":"NCT03498313","phase":"PHASE4","title":"Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2018-07-27","conditions":"Suicidal Ideation","enrollment":60},{"nctId":"NCT04225221","phase":"PHASE2","title":"Neurobiology of Bulimia Nervosa","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-02-24","conditions":"Bulimia Nervosa","enrollment":10},{"nctId":"NCT02340221","phase":"PHASE3","title":"A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2015-04-09","conditions":"Breast Cancer","enrollment":631},{"nctId":"NCT00676663","phase":"PHASE2","title":"Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer","status":"COMPLETED","sponsor":"Syndax Pharmaceuticals","startDate":"2008-06-13","conditions":"Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive","enrollment":130}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of Estrogen","genericName":"Placebo of Estrogen","companyName":"Faculdade de Medicina do ABC","companyId":"faculdade-de-medicina-do-abc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo formulation designed to mimic estrogen therapy for use as a control arm in clinical trials. Used for Control arm in Phase 3 clinical trials of estrogen-based therapies (specific indication unknown).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}